An appeal has been made to the Prime Minister by Sumanata Kumar Tiwari, the joint director-cum-drug controller of Jharkhand, for a significant overhaul of the current regulatory framework to combat the escalating menace of counterfeit medicines
.png "FDA Approves Finerenone for Broader Heart Failure Treatment")
The US Food and Drug Administration (FDA) has granted new approval for Bayer’s finerenone (Kerendia) with a new indication to treat adults with heart failure and a left ventricular ejection fraction (LVEF) of 40% or higher...
.png "PharmaJet Brings Needle-Free Vaccine Tech to Egypt's Immunization Plan")
PharmaJet has signed a strategic Memorandum of Understanding with Egypt’s Unified Procurement Authority (UPA) and leading pharmaceutical company EVA Pharma to enable introduction of needle-free vaccine delivery as part of their routine...
On Tuesday, Aurobindo Pharma announced that it will produce and distribute cabotegravir, a long-acting injectable HIV therapy, in 133 nations. According to a statement from the firm, the Hyderabad-based pharmaceutical company has been chosen as on
AstraZeneca reported encouraging top-line results from the Phase III BaxHTN trial, demonstrating baxdrostat's statistically significant and clinically significant decrease in mean seated systolic blood pressure
Baxdrostat at two doses (2 mg and 1 mg) showed a statistically significant and clinically relevant reduction in mean sitting systolic blood pressure (SBP) at 12 weeks when compared with placebo, according to positive high-level data from the BaxHTN
The World Health Organization (WHO) has taken a significant step forward by endorsing Gilead's lenacapavir, an injectable drug twice-yearly, as a preventive measure to protect against HIV. The WHO confirmed this recommendation on Monday morning...
Aayush Wellness, a leading player in the Ayurvedic and wellness segments, has announced a strategic expansion of its nutraceutical product lines in order to bolster its presence into India's robust and emerging health and wellness sector...
Sun Pharmaceutical Industries Ltd. has announced the availability of LEQSELVI (deuruxolitinib) 8 mg tablets in the U.S. to treat severe alopecia areata, a severe autoimmune disorder that unpredictably causes hair loss in adult patients.
In a substantial move for India's pharmaceutical manufacturing sector, Sun Pharmaceutical Industries has committed to an investment of Rs 3,800 crore in Madhya Pradesh, creating an estimated 2,000 new jobs...
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")